Susquehanna International Group
NERV icon

Susquehanna International Group’s Minerva Neurosciences NERV Stock Holding History

Susquehanna International Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,350
Closed -$53K – 13639
2021
Q4 		$53K Sell
8,350
-8,138
-49% -$76.6K ﹤0.01% 12516
2021
Q3 		$230K Buy
16,488
+8,925
+118% +$134K ﹤0.01% 11179
2021
Q2 		$140K Sell
7,563
-1,612
-18% -$34.7K ﹤0.01% 11894
2021
Q1 		$214K Buy
9,175
+462
+5% +$11.5K ﹤0.01% 11304
2020
Q4 		$163K Sell
8,713
-975
-10% -$24.6K ﹤0.01% 10200
2020
Q3 		$246K Sell
9,688
-31,525
-76% -$852K ﹤0.01% 9100
2020
Q2 		$1.19M Buy
41,213
+30,025
+268% +$1.76M ﹤0.01% 5526
2020
Q1 		$539K Buy
11,188
+9,125
+442% +$551K ﹤0.01% 6778
2019
Q4 		$117K Sell
2,063
-325
-14% -$14.3K ﹤0.01% 9067
2019
Q3 		$148K Sell
2,388
-50
-2% -$2.83K ﹤0.01% 9333
2019
Q2 		$110K Buy
+2,438
New +$122K ﹤0.01% 9562
2017
Q4 		– Sell
-1,838
Closed -$112K – 9684
2017
Q3 		$112K Sell
1,838
-587
-24% -$33.7K ﹤0.01% 8319
2017
Q2 		$172K Buy
+2,425
New +$157K ﹤0.01% 8415

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Susquehanna International Group's NERV Position: Q2 2026 in Review

Susquehanna International Group sold out of Minerva Neurosciences (NERV) in Q2 2026, closing a stake of 119,131 shares — an estimated $718K sold.

Susquehanna International Group first reported a position in NERV in Q1 2016 and held it in 20 quarters. The position peaked at $1.51M in Q1 2020. 61 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Susquehanna International Group reported no remaining Minerva Neurosciences position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 119,131 Minerva Neurosciences shares in Q2 2026, an estimated $718K.
  • Susquehanna International Group first reported a position in Minerva Neurosciences in Q1 2016 and held it in 20 quarters.
  • Susquehanna International Group's Minerva Neurosciences position peaked at $1.51M in Q1 2020.
  • 61 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.